Thai-hoa Tran - Publications

CSF metabolomic signature during therapy for childhood acute lymphoblastic leukemia predicts subsequent working memory impairment.

Journal: Molecular medicine (Cambridge, Mass.)

Published: October 25, 2025

Influence of xanthine oxidase and inosine monophosphate dehydrogenase polymorphisms on 6-mercaptopurine treatment response in pediatric acute lymphoblastic leukemia.

Journal: Scientific reports

Published: September 05, 2025

Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocols.

Journal: Frontiers in pediatrics

Published: August 14, 2025

Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana-Farber Cancer Institute ALL Consortium Study 16-001.

Journal: Pediatric blood & cancer

Published: August 12, 2025

Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: July 07, 2025

Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study.

Journal: The Lancet. Haematology

Published: July 03, 2025

Baseline Neurocognitive Functioning Among Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana Farber Cancer Institute ALL Consortium Study 16-001.

Journal: Pediatric blood & cancer

Published: May 14, 2025

Feasibility of Utilizing a Brief Neurocognitive Battery in 3-Year-Old Patients During Treatment for Acute Lymphoblastic Leukemia.

Journal: Pediatric blood & cancer

Published: August 07, 2024

Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort.

Journal: Pediatric blood & cancer

Published: June 05, 2024

Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients.

Journal: Pharmacogenetics and genomics

Published: April 29, 2024

Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.

Journal: Frontiers in oncology

Published: April 16, 2024

Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.

Journal: Frontiers in oncology

Published: January 25, 2024